Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo

Journal of Pharmacy and Pharmacology

Volumn 54, Issue 5, 2002, Pages 593-601

  Dass, Crispin R ^a  

^a JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA [N (N',N' DIMETHYLAMINO)ETHANECARBAMOYL]CHOLESTEROL; 4 ETHYL DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYL ROSENTHAL INHIBITOR ETHER; DRUG CARRIER; ENEMA; GAMMA INTERFERON; INTERLEUKIN 12; LIPOPLEX; LIPOSOME; NUCLEIC ACID; OLIGODEOXYNUCLEOTIDE; PLASMID DNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

CANCER; CATION TRANSPORT; CELL CULTURE; CELL DEATH; CELL INFILTRATION; CLINICAL TRIAL; CYSTIC FIBROSIS; CYTOTOXICITY TEST; DNA DRUG COMPLEX; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG FATALITY; DRUG FORMULATION; DRUG SCREENING; DRUG USE; EMBOLISM; EYE INFLAMMATION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HEMOLYSIS; HUMAN; HYPOTHERMIA; IMMUNOGENICITY; IN VIVO STUDY; INFARCTION; ISCHEMIA; KNEE DISEASE; LIVER TOXICITY; LUNG DISEASE; NEPHROTOXICITY; NONHUMAN; NUCLEIC ACID TRANSPORT; REVIEW; RISK ASSESSMENT; SEIZURE;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CYSTIC FIBROSIS; DRUG ADMINISTRATION ROUTES; DRUG DELIVERY SYSTEMS; EMBOLISM; GENE THERAPY; HUMANS; LIPIDS; LIPOSOMES; NEOPLASMS; TRANSFECTION;

EID: 0036229451     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357021778817     Document Type: Review

References (87)

1. A novel tetraester construct that reduces cationic lipid-associated cytotoxicity. Implications for the onset of cytotoxicity
2. The cell biology of macrophage activation
3. Gene transfer in vitro and in vivo by cationic lipids is not significantly affected by levels of supercoiling of a reporter plasmid
4. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers
5. Enhanced in vitro and in vivo cationic lipid-mediated gene delivery with a fluorinated glycerophosphoethanolamine helper lipid
6. Activation of host tumoral responses by cationic lipid/DNA complexes
7. Delivery and pathway in MCF7 cells of DNA vectorized by cationic liposomes derived from cholesterol
8. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
9. Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes
10. New cationic liposomes for gene transfer into mammalian cells with high efficiency and low toxicity
11. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes
12. Use of perfluorocarbon (Fluorinert) to enhance reporter gene expression following intratracheal instillation into the lungs of Balb/c mice: Implications for nebulized delivery of plasmids
13. Targeted delivery of DNA for cancer therapy
14. Lipoplexes and tumours
15. Delivery of lipoplexes for genotherapy of solid tumours: Role of vascular endothelial cells
16. A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumour model
17. Liposomes containing cationic dimethyl dioctadecyl ammonium bromide (DDAB): Formulation, quality control and lipofection efficiency
18. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously
19. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations
20. Immunomodulatory activity of some amphiphilic compounds
21. Anti-inflammatory activity of cationic lipids
22. Toxicity and immunomodulatory activity of some liposomal vectors formulated with cationic lipids toward immune effector cells
23. Major limitations in the use of cationic liposomes for DNA delivery
24. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: Cationic lipid complexes
25. Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes
26. Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular networks
27. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis
28. + hematopoietic cells
29. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery
30. Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: A Phase I clinical trial
31. Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA-liposome complexes
32. Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes
33. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis
34. A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of antisense phosphorothioate oligonucleotides
35. Amphiphilic detergents inhibit production of IgG and IgM by human peripheral blood mononuclear cells
36. Effect of polyisobutylcyanoacrylate nanoparticles and lipofectin loaded with oligonucleotides on cell viability and PKC alpha neosynthesis in HepG2 cells
37. Comparison of cell proliferation and toxicity assays using two cationic liposomes
38. Gene transfer into subcultured endometrial cells using lipofection
39. Liposomes and lipidic particles in gene therapy
40. Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line
41. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors
42. Fate of cationic liposomes and their complex with oligonucleotide in vivo
43. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes
44. Size-dependent DNA mobility in cytoplasm and nucleus
45. Efficacy of cationic liposome-mediated gene transfer to mesangial cells in vitro and in vivo
46. Toxicology of non-viral gene transfer
47. Polyinosinic acid and polycationic liposomes attenuate the hepatic clearance of circulating plasmid DNA
48. Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice
49. Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particles
50. Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma
51. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes
52. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biological activity, and lack of toxicity in humans
53. Heterogeneous induction of apoptosis in colon cancer cells by wild-type p53 gene transfection
54. A new temperature sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model
55. Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo
56. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis
57. Liposome-mediated gene transfer into human vascular smooth muscle cells
58. Efficiency and toxicity of liposome-mediated gene transfer to corneal epithelial cells
59. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
60. Promoter attenuation in gene therapy: Interferon-γ and tumor necrosis factor-α inhibit transgene expression
61. Structural basis of DOTMA for its high intravenous transfection activity in mouse
62. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis
63. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: Physicochemical and transfection studies
64. Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: The role of the neutral helper lipid
65. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: Formation of novel small multilamellar vesicle structures
66. Interaction of positively-charge liposomes with blood: Implications for their application in vivo
67. Efficient in vivo gene delivery by the negatively charged complexes of cationic liposomes and plasmid DNA
68. Gene therapy for cystic fibrosis using cationic liposome mediated gene transfer: A phase I trial of safety and efficacy in the nasal airway
69. Importance of liposome complexing volume in transfection optimization
70. Phase II study of direct intralesional gene transfer of Allovectin-7, an HLA-B7/β2-microglobulin DNA-liposome complex, in patients with metastatic melanoma
71. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1
72. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo
73. Assessment of ocular irritability of liposome preparations
74. Mechanism of lipoplex gene delivery in mouse lung: Binding and internalization of fluorescent lipid and DNA components
75. A multi-step lipid mixing assay to model structural changes in cationic lipoplexes used for in vitro transfection
76. Immunoliposome-mediated gene transfer into cultured myotubes
77. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung
78. LPD lipopolyplex initiates a potent cytokines response and inhibits tumor growth
79. Cationic lipid binding to DNA: Characterization of complex formation
80. β-Galactosidase staining following intracoronary infusion of cationic liposomes in the in vivo rabbit heart is produced by microinfarction rather than effective gene transfer: A cautionary tale
81. Preclinical and clinical study of HER-2/neu-targeting cancer gene therapy
82. In vivo gene therapy with a cationic polymer markedly enhances the antitumor activity of antiangiogenic genes
83. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA
84. Time-dependent maturation of cationic liposome-DNA complex for serum resistance
85. Reduced inflammatory response to plasmid vectors by elimination and inhibition of immunostimulatory CpG motifs
86. Cellular and molecular barriers to gene transfer by a cationic lipid
87. Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery